CBAY

Cymabay Therapeutics
CBAY

Overview Fund Activity
Delisted

CBAY was delisted on the 21st of March, 2024.

Back to rankings

106 hedge funds and large institutions have $186M invested in Cymabay Therapeutics in 2022 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 30 increasing their positions, 32 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
106
Holders Change
-12
Holders Change %
-10.17%
% of All Funds
1.79%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
20
Increased
30
Reduced
32
Closed
28
Calls
$801K
Puts
$345K
Net Calls
+$456K
Net Calls Change
+$107K

Top Buyers

1
LCM
1
Laurion Capital Management
New York
$4.65M
2
LCM
2
Lynx1 Capital Management
Puerto Rico
$7.64M
3
NCM
3
Nantahala Capital Management
Connecticut
$7.8M
4
Hudson Bay Capital Management
4
Hudson Bay Capital Management
Connecticut
$4.43M
5
Millennium Management
5
Millennium Management
New York
$8.9M

Top Sellers

1
BlackRock
1
BlackRock
New York
$5.76M
2
JPMorgan Chase & Co
2
JPMorgan Chase & Co
New York
$10K
3
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$1.48M
4
State Street
4
State Street
Massachusetts
$1.07M
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$2.1M
Name Holding Trade Value Shares
Change 		Shares
Change %
UBS Group
26
UBS Group
Switzerland
$1.34M +$1.25M +423,806 +1,347%
E
27
Ergoteles
New York
$1.21M +$1.21M +410,400 New
HS
28
HighVista Strategies
Massachusetts
$1.17M +$555K +188,025 +91%
State Street
29
State Street
Massachusetts
$1.07M -$2.94M -995,930 -73%
Point72 Asset Management
30
Point72 Asset Management
Connecticut
$1.03M +$1.03M +350,000 New
D.E. Shaw & Co
31
D.E. Shaw & Co
New York
$782K -$132K -44,941 -14%
FI
32
Fosun International
China
$778K – – –
Citigroup
33
Citigroup
New York
$774K +$758K +256,894 +4,662%
Goldman Sachs
34
Goldman Sachs
New York
$753K -$913K -309,073 -55%
PCM
35
Pinz Capital Management
New York
$683K +$683K +231,680 New
Invesco
36
Invesco
Georgia
$664K +$8.13K +2,759 +1%
Rockefeller Capital Management
37
Rockefeller Capital Management
New York
$631K -$38.8K -13,175 -6%
CM
38
CM Management
Florida
$620K +$177K +60,000 +40%
AGM
39
Alpine Global Management
New York
$584K -$154K -52,112 -21%
Two Sigma Advisers
40
Two Sigma Advisers
New York
$435K +$60.4K +20,500 +16%
Connor, Clark & Lunn Investment Management (CC&L)
41
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$430K +$232K +78,692 +117%
Northern Trust
42
Northern Trust
Illinois
$410K -$1.75M -592,728 -81%
Barclays
43
Barclays
United Kingdom
$398K +$274K +93,054 +222%
CAM
44
ClariVest Asset Management
California
$392K – – –
A
45
Abingworth
United Kingdom
$385K – – –
Deutsche Bank
46
Deutsche Bank
Germany
$375K -$111K -37,507 -23%
Bank of America
47
Bank of America
North Carolina
$365K +$145K +49,333 +66%
T. Rowe Price Associates
48
T. Rowe Price Associates
Maryland
$360K +$35.6K +12,077 +11%
Two Sigma Investments
49
Two Sigma Investments
New York
$333K +$81.1K +27,496 +32%
CANY
50
Caxton Associates (New York)
New York
$310K -$37.4K -12,700 -11%
1
2
3 4 5